BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30022967)

  • 1. Cerebrospinal Fluid Biomarkers Are Associated With Glial Fibrillary Acidic Protein and αII-spectrin Breakdown Products in Brain Tissues Following Penetrating Ballistic-Like Brain Injury in Rats.
    DeDominicis KE; Hwang H; Cartagena CM; Shear DA; Boutté AM
    Front Neurol; 2018; 9():490. PubMed ID: 30022967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Glial Fibrillary Acidic Protein Predicts Tissue Glial Fibrillary Acidic Protein Break-Down Products and Therapeutic Efficacy after Penetrating Ballistic-Like Brain Injury.
    Boutté AM; Deng-Bryant Y; Johnson D; Tortella FC; Dave JR; Shear DA; Schmid KE
    J Neurotrauma; 2016 Jan; 33(1):147-56. PubMed ID: 25789543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children.
    Metzger RR; Sheng X; Niedzwecki CM; Bennett KS; Morita DC; Zielinski B; Schober ME
    J Neurosurg Pediatr; 2018 Oct; 22(4):369-374. PubMed ID: 29957142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury.
    Robinson S; Winer JL; Berkner J; Chan LA; Denson JL; Maxwell JR; Yang Y; Sillerud LO; Tasker RC; Meehan WP; Mannix R; Jantzie LL
    J Neurosurg Pediatr; 2016 Jun; 17(6):739-55. PubMed ID: 26894518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel marker for traumatic brain injury: CSF alphaII-spectrin breakdown product levels.
    Ringger NC; O'Steen BE; Brabham JG; Silver X; Pineda J; Wang KK; Hayes RL; Papa L
    J Neurotrauma; 2004 Oct; 21(10):1443-56. PubMed ID: 15672634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT III.
    Frankel M; Fan L; Yeatts SD; Jeromin A; Vos PE; Wagner AK; Wolf BJ; Pauls Q; Lunney M; Merck LH; Hall CL; Palesch YY; Silbergleit R; Wright DW
    J Neurotrauma; 2019 Oct; 36(20):2863-2871. PubMed ID: 30794101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of alphaII-spectrin and breakdown products in humans after severe traumatic brain injury.
    Cardali S; Maugeri R
    J Neurosurg Sci; 2006 Jun; 50(2):25-31. PubMed ID: 16841024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury.
    Pineda JA; Lewis SB; Valadka AB; Papa L; Hannay HJ; Heaton SC; Demery JA; Liu MC; Aikman JM; Akle V; Brophy GM; Tepas JJ; Wang KK; Robertson CS; Hayes RL
    J Neurotrauma; 2007 Feb; 24(2):354-66. PubMed ID: 17375999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers track damage after graded injury severity in a rat model of penetrating brain injury.
    Zoltewicz JS; Mondello S; Yang B; Newsom KJ; Kobeissy F; Yao C; Lu XC; Dave JR; Shear DA; Schmid K; Rivera V; Cram T; Seaney J; Zhang Z; Wang KK; Hayes RL; Tortella FC
    J Neurotrauma; 2013 Jul; 30(13):1161-9. PubMed ID: 23409698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein Biomarkers and Neuroproteomics Characterization of Microvesicles/Exosomes from Human Cerebrospinal Fluid Following Traumatic Brain Injury.
    Manek R; Moghieb A; Yang Z; Kumar D; Kobessiy F; Sarkis GA; Raghavan V; Wang KKW
    Mol Neurobiol; 2018 Jul; 55(7):6112-6128. PubMed ID: 29188495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Temporal Profiles of Serum Levels of UCH-L1 and GFAP and Relationships to Neuronal and Astroglial Pathology following Traumatic Brain Injury in Rats.
    Huang XJ; Glushakova O; Mondello S; Van K; Hayes RL; Lyeth BG
    J Neurotrauma; 2015 Aug; 32(16):1179-89. PubMed ID: 25763798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal Profile and Severity Correlation of a Panel of Rat Spinal Cord Injury Protein Biomarkers.
    Yang Z; Bramlett HM; Moghieb A; Yu D; Wang P; Lin F; Bauer C; Selig TM; Jaalouk E; Weissman AS; Rathore DS; Romo P; Zhang Z; Hayes RL; Wang MY; Dietrich WD; Wang KKW
    Mol Neurobiol; 2018 Mar; 55(3):2174-2184. PubMed ID: 28290147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Anti-Glial Fibrillary Acidic Protein Autoantibody Levels during the Acute and Chronic Phases of Traumatic Brain Injury: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot Study.
    Wang KK; Yang Z; Yue JK; Zhang Z; Winkler EA; Puccio AM; Diaz-Arrastia R; Lingsma HF; Yuh EL; Mukherjee P; Valadka AB; Gordon WA; Okonkwo DO; Manley GT; Cooper SR; Dams-O'Connor K; Hricik AJ; Inoue T; Maas AI; Menon DK; Schnyer DM; Sinha TK; Vassar MJ
    J Neurotrauma; 2016 Jul; 33(13):1270-7. PubMed ID: 26560343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insight into Pre-Clinical Models of Traumatic Brain Injury Using Circulating Brain Damage Biomarkers: Operation Brain Trauma Therapy.
    Mondello S; Shear DA; Bramlett HM; Dixon CE; Schmid KE; Dietrich WD; Wang KK; Hayes RL; Glushakova O; Catania M; Richieri SP; Povlishock JT; Tortella FC; Kochanek PM
    J Neurotrauma; 2016 Mar; 33(6):595-605. PubMed ID: 26671651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury.
    Brophy GM; Pineda JA; Papa L; Lewis SB; Valadka AB; Hannay HJ; Heaton SC; Demery JA; Liu MC; Tepas JJ; Gabrielli A; Robicsek S; Wang KK; Robertson CS; Hayes RL
    J Neurotrauma; 2009 Apr; 26(4):471-9. PubMed ID: 19206997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats.
    Pike BR; Flint J; Dutta S; Johnson E; Wang KK; Hayes RL
    J Neurochem; 2001 Sep; 78(6):1297-306. PubMed ID: 11579138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients.
    Mondello S; Robicsek SA; Gabrielli A; Brophy GM; Papa L; Tepas J; Robertson C; Buki A; Scharf D; Jixiang M; Akinyi L; Muller U; Wang KK; Hayes RL
    J Neurotrauma; 2010 Jul; 27(7):1203-13. PubMed ID: 20408766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of calpain and caspase-3 proteolytic fragments of brain-derived alphaII-spectrin in cerebral spinal fluid after middle cerebral artery occlusion in rats.
    Pike BR; Flint J; Dave JR; Lu XC; Wang KK; Tortella FC; Hayes RL
    J Cereb Blood Flow Metab; 2004 Jan; 24(1):98-106. PubMed ID: 14688621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of α-II-spectrin breakdown products in the prediction of the severity and clinical outcome of acute traumatic brain injury.
    Chen S; Shi Q; Zheng S; Luo L; Yuan S; Wang X; Cheng Z; Zhang W
    Exp Ther Med; 2016 May; 11(5):2049-2053. PubMed ID: 27168849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator.
    Czeiter E; Mondello S; Kovacs N; Sandor J; Gabrielli A; Schmid K; Tortella F; Wang KK; Hayes RL; Barzo P; Ezer E; Doczi T; Buki A
    J Neurotrauma; 2012 Jun; 29(9):1770-8. PubMed ID: 22435839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.